The role of retinoids in the induction of nerve growth factor: a potential treatment for diabetic neuropathy
Author:
- 1 September 2014
- journal article
- editorial
- Published by Elsevier in Translational Research
- Vol. 164 (3) , 193-195
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Diabetic NeuropathyEndocrinology and Metabolism Clinics of North America, 2013
- Approaches for Neural Tissue RegenerationStem Cell Reviews and Reports, 2013
- Structural, biological, and pharmacological strategies for the inhibition of nerve growth factorNeurochemistry International, 2012
- Nerve growth factor: from the early discoveries to the potential clinical useJournal of Translational Medicine, 2012
- The Neurotrophin Family of Neurotrophic Factors: An Overview2012
- Unraveling the Story of NGF-mediated Sensitization of Nociceptive Sensory Neurons: ON or OFF the Trks?Molecular Interventions, 2007
- p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat HyperalgesiaNeuron, 2002
- A role for mitogen‐activated protein kinases in the etiology of diabetic neuropathyThe FASEB Journal, 2001
- Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factorMolecular Brain Research, 1994
- Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathyJournal of Neuroscience Research, 1990